Dianthus Therapeutics (DNTH) PT Raised to $44 at Wedbush
Tweet
Share
E-mailGet Alerts DNTH Hot Sheet
Price: $112.41 +3.61%
Rating Summary:
15 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 6 | New: 3
Rating Summary:
15 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 6 | New: 3
Join SI Premium – FREE
Wedbush analyst Laura Chico raised the price target on Dianthus Therapeutics (NASDAQ: DNTH) to $44.00 (from $42.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Citi Upgrades Suzuki Motor Corp (7269:JP) (SZKMY) to Buy
- Samvardhana Motherson International (MOTHERSO:IN) PT Raised to INR170 at JPMorgan
- Agomab Announces Proposed Appointments of Marino Garcia and Dr. Naimish Patel to Board of Directors
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
